Corporate
Sarepta's ELEVIDYS Shows 70%+ Disease Slowing at 3 Years—Stock Surges 13% on Redemption Data
Jan 26
You're signed outSign in or to get full access.
Sarepta Therapeutics (SRPT) Earnings Call Transcripts
Browse quarterly earnings call transcripts for Sarepta Therapeutics.
Q3 2025
Nov 3, 2025
Q1 2025
May 6, 2025
Q4 2024
Feb 26, 2025
Q3 2024
Nov 6, 2024
Q2 2024
Aug 7, 2024